Jack Kit‐Chung Ng

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Peritoneal Dialysis Catheter Revision and Replacement by Nephrologist for Peritoneal Dialysis Catheter Malfunction

Terry King‐Wing, Kai Ming Chow, Bonnie Ching‐Ha Kwan et al. · ˜The œNephron journals/Nephron journals · 2017 · 145 citations

Asymptomatic fluid overload predicts survival and cardiovascular event in incident Chinese peritoneal dialysis patients

Jack Kit‐Chung Ng, Bonnie Ching‐Ha Kwan, Kai‐Ming Chow et al. · PLoS ONE · 2018 · 56 citations · Full text

Circulating Bacterial-Derived DNA Fragment Level Is a Strong Predictor of Cardiovascular Disease in Peritoneal Dialysis Patients

Cheuk‐Chun Szeto, Bonnie Ching‐Ha Kwan, Kai‐Ming Chow et al. · PLoS ONE · 2015 · 46 citations · Full text